Immune cell state may help explain how cytomegalovirus evades body's defenses
Human cytomegalovirus (HCMV) is a major global health burden that causes lifelong infection in humans. It is the leading infectious cause of developmental disabilities in children and can be life-threatening to individuals with a weakened immune system, for example, in transplant patients. Despite 70 years of research on HCMV, it is still not fully understood how the virus evades immune control.
Cytomegalovirus (HCMV) is a widespread virus that causes lifelong infections and can lead to severe health issues, particularly in individuals with weakened immune systems, such as transplant patients. Despite extensive research, the mechanisms behind the virus's immune evasion are still unclear. A new study conducted by researchers at TWINCORE has shed light on this by investigating how HCMV manages to escape immune surveillance.
Dendritic cells (DCs) are crucial for the immune system, as they detect pathogens and initiate the adaptive immune response by activating other immune cells, especially T cells. HCMV targets these DCs, but the factors determining their susceptibility to infection have not been well-defined. Previous research identified a specific group of monocyte-derived DCs (moDCs) with altered surface markers and gene expression, which supported viral gene expression more efficiently than others.
In this study, researchers from TWINCORE generated tolerant dendritic cells (tolDCs) using vitamin D3 (VitD3), dexamethasone (Dexa), or their combination. They discovered that tolDCs generated with Dexa alone or in combination with VitD3 resisted maturation, while those treated with VitD3 alone remained more responsive to activating signals.
HCMV exposure made these tolDCs more susceptible to infection but also less capable of stimulating T-cell responses. Despite their increased infection risk, HCMV-exposed tolDCs activated T cells poorly and had reduced levels of molecules that present viral components to T cells, along with lower levels of costimulatory markers required for successful T-cell activation.
The researchers concluded that tolerogenic DCs could serve as a favorable environment for HCMV, allowing the virus to benefit from their reduced immune-stimulatory capacity. This discovery paves the way for the identification of specific immune cells vulnerable to HCMV and could lead to the development of more targeted therapies. Further research is needed to determine if similar cell populations contribute to HCMV infection and immune evasion in humans.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.